Characterization of breast cancer subtypes has evolved using molecular subtyping techniques, notably the PAM50 classification, which categorizes breast cancers into intrinsic subtypes, including luminal A, luminal B, HER2+, and triple-negative breast cancer (TNBC). This evidence concerns the gene ERBB2 and breast cancer.